Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telemedicine MOUD and PrEP for PWID at SSPs
NCT04521920Completed
- Sponsor
- Duke University
- Start
- Nov 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Suboxone in opioid use disorder (OUD) and human immunodeficiency virus infection (HIV), sponsored by Duke University. Primary endpoints: Number of Participants Who Demonstrate no or Minimal Opioid Use at 6 months, Number of Participants Who Remain HIV Negative at 6 months and 1 more. Started Nov 2020; status: completed.
02
Drugs
Suboxone
03
Conditions
opioid use disorder (OUD)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04521920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521920.